Arrowhead Pharmaceuticals, Inc. Share Price
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 USD | +1.14% | -0.94% | -27.71% |
Sales 2024 * | 126M 10.07B | Sales 2025 * | 179M 14.36B | Capitalization | 2.74B 219B |
---|---|---|---|---|---|
Net income 2024 * | -313M -25.06B | Net income 2025 * | -304M -24.34B | EV / Sales 2024 * | 18.4 x |
Net cash position 2024 * | 426M 34.13B | Net cash position 2025 * | 313M 25.08B | EV / Sales 2025 * | 13.5 x |
P/E ratio 2024 * |
-8.1
x | P/E ratio 2025 * |
-8.64
x | Employees | 525 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.51% |
Latest transcript on Arrowhead Pharmaceuticals, Inc.
1 day | +1.14% | ||
1 week | -0.94% | ||
Current month | -22.66% | ||
1 month | -22.93% | ||
3 months | -32.46% | ||
6 months | -6.27% | ||
Current year | -27.71% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 30/11/07 | |
Director of Finance/CFO | 57 | 31/12/08 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 22/11/10 |
Michael Perry
BRD | Director/Board Member | 64 | 18/12/11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 31/08/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.40% | 0 M€ | 0.00% | - | |
0.35% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 22.12 | +1.14% | 617,126 |
25/04/24 | 21.87 | -6.10% | 976,870 |
24/04/24 | 23.29 | -2.06% | 813,628 |
23/04/24 | 23.78 | -0.59% | 828,397 |
22/04/24 | 23.92 | +7.12% | 1,080,438 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.71% | 2.74B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARWR Stock